Search PubMed⌕ Search

PubMed · 10142831

Hand-held computers.

Abstract

Changes in healthcare delivery, such as patient-focused, point-of-service care, demand that data be entered and accessed at the site where the patient is located (bedside, ER, home, ambulance). But this is not possible without some type of portable information system. The first step to bring information to the patient's side was through the use of bedside computers, but this delivery method has received limited acceptance. At present, some hospitals have begun to use hand-held computers that follow the healthcare clinician, not the patient. Why? Fewer terminals are needed. Handhelds have become easier to use with intuitive graphical user interfaces. As the size of computers has decreased, so has the cost. Personal-sized assistants come in many formats, using proprietary or off the shelf software, or bar code attachments, and with various ports for card or cable access. Most people are becoming computer literate, adapting to downloading, recharging, inserting, and pen/keystroking.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J M Cribb. 1995. Hand-held computers.. https://pubmed.ncbi.nlm.nih.gov/10142831/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Coding-complete genome sequence of grapevine leafroll-associated virus 13 from grapevine in California.

In this study, we report the coding-complete genome sequence of Grapevine leafroll-associated virus 13 (GLRaV-13), isolate CA8881, detected in Vitis vinifera in California, USA. The genome sequence exhibited over 95% nucleotide identity with previously reported GLRaV-13 isolates and contributed to better understanding of the genetic diversity of ampeloviruses infecting grapevine.

California↗

Changing relationship between socioeconomic status and prostate cancer incidence.

BACKGROUND: Understanding the relationship between socioeconomic status (SES) and prostate cancer incidence could identify populations that should be targeted for intervention and prevention programs. We examined this relationship within the major racial/ethnic groups during the period 1972 through 1997, which spans the introduction of prostate-specific antigen (PSA) testing. METHODS: We used data from the population-based Los Angeles Cancer Surveillance Program to examine age-adjusted prostate cancer incidence rates in five SES groups over three specific calendar periods by racial/ethnic subpopulation (white, black, Asian, and Hispanic) and by stage of disease at diagnosis. Linear regression analysis was used to test for trends in the age-adjusted incidence rates that were associated with increasing levels of SES. All P values were two-sided. RESULTS: For men diagnosed with prostate cancer before 1987, when the test for PSA was not widely available, we found no association between SES and the incidence of prostate cancer in any of four racial/ethnic subpopulations or between SES and the stage of disease at diagnosis. In contrast, among men who were diagnosed with prostate cancer after 1987, SES was statistically significantly and positively associated with prostate cancer incidence in men from all racial/ethnic subpopulations except Asians (P =.01 for white men, P =.001 for black men, P =.02 for Hispanic men, P =.06 for Asian men, and P =.01 for all men combined). Higher SES was statistically significantly associated with cancers of earlier stage (P =.01 for localized cancer and P =.00 for regional cancer) for men who were diagnosed with prostate cancer after 1987. CONCLUSIONS: The association between SES and prostate cancer incidence after 1987 may reflect more prevalent PSA screening in populations with higher SES due to their greater access to health care. SES should, therefore, be considered an important factor in interpreting variations and time trends in prostate cancer incidence.

California↗